Posted on 4 月 17, 20234/17/23
What EVERSANA’s Growing Abstract Count at ISPOR U.S. Means to the HEOR Industry
Posted on 3 月 1, 20233/1/23
Filling the Missing Spaces in Your Network Meta-Analysis: The Role of Surrogate Models
Posted on 2 月 27, 20232/27/23
Single-Arm Data: Turning Limitations into Strengths with Numbers
Posted on 2 月 27, 20232/27/23
Eight Key Strategic Considerations When Launching a Global Indirect Treatment Comparison Program for New Products
Posted on 2 月 8, 20232/8/23